About Emergentec
Emergentec is a company based in Vienna (Austria) founded in 2002.. Emergentec offers products and services including OPA i, Computational Vaccinology Platform, Knowledge Graph Platform, Image Analysis Platform, and Digital Drug R&D Platform. Emergentec operates in a competitive market with competitors including Aganitha, Cellumen, PointCross, IOTA Pharma and Growdea Technologies, among others.
- Headquarter Vienna, Austria
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Emergentec Biodevelopment Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$1.31 M (USD), Grant
Jan 01, 2020
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Emergentec
Emergentec offers a comprehensive portfolio of products and services, including OPA i, Computational Vaccinology Platform, Knowledge Graph Platform, Image Analysis Platform, and Digital Drug R&D Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool for phenotype analysis and personalized treatment predictions.
Platform for vaccine development using data-driven simulations.
System for organizing and analyzing health research data networks.
Software for processing and interpreting medical images.
Platform for in-silico drug positioning and repositioning processes.
Funding Insights of Emergentec
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $1.3M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Grant - Emergentec | Valuation |
investors |
|
| Jan, 2016 | Amount | Grant - Emergentec | Valuation |
investors |
|
| Jan, 2010 | Amount | Grant - Emergentec | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Emergentec
Emergentec has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Emergentec
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Emergentec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Emergentec Comparisons
Competitors of Emergentec
Emergentec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aganitha, Cellumen, PointCross, IOTA Pharma and Growdea Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-powered drug discovery and development solutions
|
|
| domain | founded_year | HQ Location |
Systems biology solutions for drug safety and efficacy are provided.
|
|
| domain | founded_year | HQ Location |
Big data platform & desktop software for preclinical & clinical research & regulatory applications
|
|
| domain | founded_year | HQ Location |
Offers fragment-based drug discovery products and services.
|
|
| domain | founded_year | HQ Location |
Offers AI and machine learning for in-silico drug discovery and bioinformatics services.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Emergentec
When was Emergentec founded?
Emergentec was founded in 2002 and raised its 1st funding round 8 years after it was founded.
Where is Emergentec located?
Emergentec is headquartered in Vienna, Austria.
What does Emergentec do?
emergenTEC, founded by a team of molecular biology and computer science researchers offers products and services for informed decision making in biomarker, target and drug development at all stages - preclinical, clinical and translational. Their software platform e.valuation (which is loaded with data and models, a big data solution) offers integrated workflows for conducting molecular asset evaluation in all stages of drug development. At the clinical stage it helps in deriving biomarker candidate panels for molecular phenotype profilingdrug response measurement, and at the preclinical stage to help in prioritizing on which biomarker, target or drug lead.
Who are the top competitors of Emergentec?
Emergentec's top competitors include Aganitha, Cellumen and PointCross.
What products or services does Emergentec offer?
Emergentec offers OPA i, Computational Vaccinology Platform, Knowledge Graph Platform, Image Analysis Platform, and Digital Drug R&D Platform.
Who are Emergentec's investors?
Emergentec has 1 investor. Key investors include European Union.